EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The role of sarcopenic obesity for the prediction of prognosis of patients with gastrointestinal cancer

Wenqing Chen, Qinggang Yuan, Xiangrui Li, Jiashu Yao, Lihua Yuan, Xiaotian Chen, Bo Gao iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.7452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Wenqing Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Sarcopenia, Gastrointestinal Neoplasms, Obesity. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Medical Technology of Nanjing Drum Tower Hospital, Science Foundation of Nanjing Drum Tower Hospital, Institute of Hospital Management, Nanjing University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenic obesity (SO) in patients with gastrointestinal cancer is associated with a poor prognosis. We aimed to investigate the prognostic impact of SO in patients with gastrointestinal cancer, as well as the diagnostic cut‐off value of SO in patients with gastrointestinal cancer among Chinese population.

Methods

We conducted a consecutive cohort study. Between January 2017 and January 2019, 289 patients diagnosed with gastrointestinal cancer were included in our study. Skeletal muscle area, total fat area, and subcutaneous fat area were measured by CT scan. All patients were followed up for 5 years. Receiver operating characteristic curves (ROC) were adopted to determine the cut‐off values of visceral fat obesity for the prediction of sarcopenia. Based on the cut‐off values, patients with sarcopenia combined with visceral fat obesity were divided into the SO group, and the others were divided into the non‐sarcopenic obesity (NSO) group. Kaplan–Meier curves and univariate and multivariate Cox proportional hazard models were employed to explore the associations of body composition profiles with 5‐year overall survival and disease‐specific survival.

Results

Obtained from Youden's Index for ROC for the prediction of 5‐year survival, skeletal muscle mass index (SMI) ≤40.02 cm 2 /m 2 with VFA ≥ 126.30 cm 2 in men and SMI ≤32.05 cm 2 /m 2 with VFA ≥72.42 cm 2 in women indicate a risk of poor prognosis in patients diagnosed with gastrointestinal cancer. Patients with SO had poorer 5‐year overall survival (OS) than patients with NSO (6.74% vs. 82.84%, p < 0.001), and poorer 5‐year DFS (6.74% vs. 81.82%, p < 0.001). In multivariate analysis, we found that the long‐term mortality risk was approximately 13‐fold higher among patients in the SO group compared to those with no conditions.

Conclusions

Preoperative assessment of SO is useful not only for monitoring nutritional status but also for predicting 5‐year OS in gastrointestinal cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaGastrointestinal NeoplasmsObesityHumansMaleFemalePrognosisMiddle AgedAgedBody CompositionROC CurveMuscle, SkeletalKaplan-Meier EstimateIntra-Abdominal Fat

Stichwörter der Autor:innen

gastrointestinal cancernutritionsarcopeniasarcopenic obesity

Autor:innen und Institutionen

  • Department of Clinical Nutrition, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
  • Department of General Surgery, Nanjing Drum Tower Hospital Clinical College of Xuzhou Medical University, Nanjing, Jiangsu, China.
  • Department of Interventional Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.

ORCID-Profile: Bo Gao

Förderung

  • New Medical Technology of Nanjing Drum Tower Hospital
  • Science Foundation of Nanjing Drum Tower Hospital
  • Institute of Hospital Management, Nanjing University

Zitieren

APA

Chen, W., Yuan, Q., Li, X., Yao, J., Yuan, L., Chen, X., & Gao, B. (2024). The role of sarcopenic obesity for the prediction of prognosis of patients with gastrointestinal cancer. Cancer Medicine. https://doi.org/10.1002/cam4.7452

Vancouver

Chen W, Yuan Q, Li X, Yao J, Yuan L, Chen X, et al. The role of sarcopenic obesity for the prediction of prognosis of patients with gastrointestinal cancer. Cancer Medicine. 2024. doi:10.1002/cam4.7452

BibTeX
@article{Chen2024,
  author = {Chen, Wenqing and Yuan, Qinggang and Li, Xiangrui and Yao, Jiashu and Yuan, Lihua and Chen, Xiaotian and Gao, Bo},
  title = {The role of sarcopenic obesity for the prediction of prognosis of patients with gastrointestinal cancer},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7452}
}
Kostenlos starten →